Vasopressin receptor antagonist OPC-31260 prevents cerebral oedema after subarachnoid haemorrhage. (Q48290627)

10 February 2018

title

Vasopressin receptor antagonist OPC-31260 prevents cerebral oedema after subarachnoid haemorrhage. (English)

1 reference

10 February 2018

0 references

László FA

1

1 reference

10 February 2018

Varga C

series ordinal

2

1 reference

10 February 2018

Nakamura S

series ordinal

3

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 January 1999

1 reference

10 February 2018

European Journal of Pharmacology

published in

1 reference

10 February 2018

volume

364

1 reference

10 February 2018

issue

2-3

1 reference

10 February 2018

page(s)

115-122

1 reference

10 February 2018

THE PERMEABILITY OF CAPILLARIES IN VARIOUS ORGANS AS DETERMINED BY USE OF THE 'INDICATOR DIFFUSION' METHOD.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900836-X

Syndrome of Inappropriate Secretion of Antidiuretic Hormone after Subara chnoid Hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900836-X

Brain water accumulation after the central administration of vasopressin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900836-X

Involvement of vasopressin in brain edema formation: further evidence obtained from the Brattleboro diabetes insipidus rat with experimental subarachnoid hemorrhage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900836-X

The distribution of vasopressin and oxytocin in the rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900836-X

Therapeutic efficacy of non-peptide ADH antagonist OPC-31260 in SIADH rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900836-X

Hyponatremia and renal wasting of sodium in patients with malfunction of the central nervous system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900836-X

Antidiuretic activity in the cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900836-X

Chronic blockade of vasopressin receptors in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900836-X

Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900836-X

Adenylate cyclase activity along the rabbit nephron as measured in single isolated segments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900836-X

Vasopressin in human cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900836-X

Role of cerebral endothelium in brain oedema.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900836-X

Hyponatremia in Subarachnoid Hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900836-X

Antidiuretic activity and immunoreactive arginin-vasopressin levels in eye plexus blood during passive avoidance behavior in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900836-X

Osmoregulation of arginine-8-vasopressin secretion in primary hypothyroidism and in Addison's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900836-X

Prevention of cerebral edema by the vasopressin antagonist d(CH2)5D-Ile2Ile4Ala9AVP in rats with experimental subarachnoid hemorrhage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900836-X

Cerebral oedema after subarachnoid haemorrhage. Pathogenetic significance of vasopressin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900836-X

Impaired water metabolism and cerebral oedema following experimental subarachnoid haemorrhage in rats(1.).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900836-X

Receptors to vasopressin and other hormones in the mammalian kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900836-X

Potent aquaretic agent. A novel nonpeptide selective vasopressin 2 antagonist (OPC-31260) in men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900836-X

Effects of vasopressin V1 and V2 receptor antagonists on progressive renal failure in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900836-X

Regulation of brain water permeability by centrally-released vasopressin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900836-X

Acute aquaresis by the nonpeptide arginine vasopressin (AVP) antagonist OPC-31260 improves hyponatremia in patients with syndrome of inappropriate secretion of antidiuretic hormone (SIADH)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900836-X

Aquaretic effects of the nonpeptide V2 antagonist OPC-31260 in hydropenic humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900836-X

Critical differences between species in the in vivo and in vitro renal responses to antidiuretic hormone antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900836-X

A specific antagonist of vasopressin produced plasma hyperosmolality and reduced ischemic-induced cerebral edema in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900836-X

In vivo diuretic effect of a new non-peptide arginine vasopressin antagonist, OPC-31260, in conscious rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900836-X

Therapeutic efficacy of the non-peptide AVP antagonist OPC-31260 in cirrhotic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900836-X

Neuroendocrinology of Cerebrospinal Fluid: Peptides, Steroids, and Other Hormones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900836-X

Characterization of a novel aquaretic agent, OPC-31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900836-X

Can neurohypophysial hormones cross the blood-cerebrospinal fluid barrier?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900836-X

Hyponatremia and increased secretion of vasopressin induced by vincristine administration in rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900836-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(98)00836-X

1 reference

10 February 2018

1 reference

10 February 2018